The newest research did, however, confirm that support groups improved quality of life for the participants, and showed a survival benefit for a subgroup of patients with an aggressive form of breast cancer.
"We didn't confirm earlier observations that group psychotherapy extends overall survival for women with metastatic breast cancer, but we did again show a positive effect on mood and pain," said Spiegel, professor and associate chair of psychiatry and behavioral sciences. "I still very much believe this type of therapy is crucial to cancer care."
The paper will be published in the Sept. 1 issue of CANCER, the journal of the American Cancer Society, and will appear in the online version of the journal on July 23.
Spiegel is well-known for his work on support groups for cancer patients. His studies and others have previously shown the groups can lead to better coping, improved mood, and reduced pain, depression and anxiety for cancer patients. When Spiegel started his research in the 1970s, virtually no cancer patients were in support groups, he said, but now the therapy is a much more accepted part of cancer care.
"Almost every cancer center, including Stanford's, offers some sort of support group," he pointed out.
In 1989, Spiegel garnered the attention of oncologists and others when he published a study in the journal The Lancet showing dramatic benefits of support groups. His study of 86 metastatic breast cancer patients found those women who were randomly assigned to attend support groups for one year experienced less depression and pain and also wound up living 18 months longer (37 vs. 19 months) than those who weren't. "We were shocked when we saw the magnitude of the effect," Spiegel told the New York Times that year.
In the years since, numerous researchers have attempted to replicate Spiegel's findings, with mixed results. According to Spiegel, four other published trials found that the therapy produced both psychological and survival benefits; this includes a recently published Journal of Clinical Oncology study with a 10-year follow-up. Six published studies, including a 2001 New England Journal of Medicine study involving 235 metastatic breast cancer patients, found that group therapy helped improve quality of life but did not lengthen survival.
Spiegel launched the latest prospective study in 1991, tracking 125 metastatic breast cancer patients for periods of up to 10 years in an effort to replicate his original findings. The women, whose cancers were comparable in type and prognosis, were randomly assigned to either group support, psychotherapy and educational materials, or to educational materials alone. The 64 women assigned to group support met for 90 minutes once a week for at least one year; some participated for as long as 10 years. Spiegel recalls one participant remarking, "This group is the least superficial thing I do in my life."
After tracking the women for more than a decade, Spiegel and his colleagues found an improvement in the therapy participants' level of distress, anxiety and pain. They did not, however, find a difference in overall survival between those women who attended therapy and those who didn't. The women who attended group therapy had a median survival of 31 months, and the group that received education materials alone survived a median of 33 months.
"The big question was whether there was an overall survival advantage for those people in therapy, and the answer was no," said Spiegel. "I was surprised and a little disappointed by the findings."
One possibility for the difference between his earlier study and this one, Spiegel said, is that both the medical treatments and the emotional climate for breast cancer patients have improved dramatically, making it more likely for patients to live longer even without the benefit of psychotherapy.
Spiegel notes that he and his colleagues did find psychotherapy benefited women with estrogen receptive-negative tumors, an aggressive type of breast cancer that fails to respond to the newest hormonal treatments. These women - who comprised 20 percent of the study group - had a median survival of almost 30 months, which was 21 months longer than those who received educational literature alone.
"Had we not found this sub-group effect, I might have said we're done doing research in this area," said Spiegel. "But this finding looks really interesting, and it's something to continue studying."
Spiegel said that despite the overall findings on survival, it remains "very clear" that support groups provide great benefits to cancer patients and should be an important part of treatment. "I've never told my patients to join a support group because it makes you live longer - I've said to do it because it helps you to live better," he said.
Michelle Brandt | EurekAlert!
Smart Data Transformation – Surfing the Big Wave
02.12.2016 | Fraunhofer-Institut für Angewandte Informationstechnik FIT
Climate change could outpace EPA Lake Champlain protections
18.11.2016 | University of Vermont
A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.
Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...
In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.
“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...
The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.
The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...
Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water
In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...
The efficiency of power electronic systems is not solely dependent on electrical efficiency but also on weight, for example, in mobile systems. When the weight of relevant components and devices in airplanes, for instance, is reduced, fuel savings can be achieved and correspondingly greenhouse gas emissions decreased. New materials and components based on gallium nitride (GaN) can help to reduce weight and increase the efficiency. With these new materials, power electronic switches can be operated at higher switching frequency, resulting in higher power density and lower material costs.
Researchers at the Fraunhofer Institute for Solar Energy Systems ISE together with partners have investigated how these materials can be used to make power...
16.11.2016 | Event News
01.11.2016 | Event News
14.10.2016 | Event News
02.12.2016 | Medical Engineering
02.12.2016 | Agricultural and Forestry Science
02.12.2016 | Physics and Astronomy